Genomic Index of Sensitivity to Chemotherapy for Triple Negative Breast Cancer

OBJECTIVE: Patients with triple-negative breast cancer (TNBC) frequently develop resistance to chemotherapy. Studies have shown that microRNAs (miRNAs) are often aberrantly expressed in TNBC and are associated with drug resistance. However, a prognostic strategy that correlates miRNAs with chemother...

Descripción completa

Detalles Bibliográficos
Autores principales: C, Ahammad Sameer, Shah, Manan, Nandy, Dipayan, Gupta, Reeshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505887/
https://www.ncbi.nlm.nih.gov/pubmed/37378935
http://dx.doi.org/10.31557/APJCP.2023.24.6.2043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505887/
https://www.ncbi.nlm.nih.gov/pubmed/37378935
http://dx.doi.org/10.31557/APJCP.2023.24.6.2043

Ejemplares similares